tradingkey.logo

Intuitive Surgical Inc

ISRG
534.280USD
+4.260+0.80%
Cierre 10/31, 16:00ETCotizaciones retrasadas 15 min
189.62BCap. mercado
69.03P/E TTM

Intuitive Surgical Inc

534.280
+4.260+0.80%

Más Datos de Intuitive Surgical Inc Compañía

Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.

Información de Intuitive Surgical Inc

Símbolo de cotizaciónISRG
Nombre de la empresaIntuitive Surgical Inc
Fecha de salida a bolsaJun 13, 2000
Director ejecutivoMr. David J. Rosa
Número de empleados15638
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 13
Dirección1020 Kifer Road
CiudadSUNNYVALE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94086
Teléfono14085232100
Sitio Webhttps://www.intuitive.com/en-us/about-us/company
Símbolo de cotizaciónISRG
Fecha de salida a bolsaJun 13, 2000
Director ejecutivoMr. David J. Rosa

Ejecutivos de Intuitive Surgical Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.28M
+0.56%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
234.20K
+1.08%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
--
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+6.02%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+31.17%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
2.35K
+46.01%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
979.00
+307.92%
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
852.00
-55.81%
Mr. Lewis Chew
Mr. Lewis Chew
Independent Director
Independent Director
783.00
+1679.55%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.28M
+0.56%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
234.20K
+1.08%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
--
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+6.02%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+31.17%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Instruments and accessories
1.47B
60.41%
Systems
574.70M
23.55%
Services
391.20M
16.03%
Por regiónUSD
Nombre
Ganancia
Proporción
U.S.
1.63B
66.78%
Outside of United states
810.60M
33.22%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Instruments and accessories
1.47B
60.41%
Systems
574.70M
23.55%
Services
391.20M
16.03%

Estadísticas de accionistas

Actualizado: jue., 15 de may
Actualizado: jue., 15 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.36%
BlackRock Institutional Trust Company, N.A.
5.39%
State Street Investment Management (US)
4.39%
T. Rowe Price Associates, Inc.
3.63%
Fidelity Management & Research Company LLC
2.38%
Otro
74.86%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.36%
BlackRock Institutional Trust Company, N.A.
5.39%
State Street Investment Management (US)
4.39%
T. Rowe Price Associates, Inc.
3.63%
Fidelity Management & Research Company LLC
2.38%
Otro
74.86%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
51.39%
Investment Advisor/Hedge Fund
26.50%
Bank and Trust
2.49%
Research Firm
2.48%
Pension Fund
2.39%
Hedge Fund
2.10%
Sovereign Wealth Fund
1.44%
Individual Investor
0.51%
Family Office
0.27%
Otro
10.43%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
3633
315.42M
88.97%
-7.70M
2025Q2
3621
320.38M
89.37%
-5.49M
2025Q1
3598
321.67M
89.74%
-4.21M
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
2023Q2
2932
311.78M
88.97%
-2.17M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
33.18M
9.25%
+665.50K
+2.05%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
19.09M
5.33%
+173.01K
+0.91%
Jun 30, 2025
State Street Investment Management (US)
15.55M
4.34%
+182.87K
+1.19%
Jun 30, 2025
T. Rowe Price Associates, Inc.
12.88M
3.59%
-374.28K
-2.82%
Jun 30, 2025
Fidelity Management & Research Company LLC
8.43M
2.35%
-1.01M
-10.67%
Jun 30, 2025
Geode Capital Management, L.L.C.
8.19M
2.28%
+109.90K
+1.36%
Jun 30, 2025
Capital World Investors
7.61M
2.12%
+93.64K
+1.25%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
7.34M
2.05%
-25.92K
-0.35%
Aug 31, 2025
JP Morgan Asset Management
4.92M
1.37%
-629.12K
-11.33%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
4.73M
1.32%
+127.12K
+2.76%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 2 de oct
Actualizado: jue., 2 de oct
Nombre
Proporción
Langar Global HealthTech ETF
14.08%
iShares U.S. Medical Devices ETF
13.62%
Simplify Health Care ETF
6.65%
First Trust Nasdaq Lux Digi Health Solutions ETF
6.58%
Global X Robotics & Artificial Intelligence ETF
6.53%
Invesco AI and Next Gen Software ETF
5%
Goldman Sachs Future Health Care Equity ETF
4.73%
iShares US Select Equity Active ETF
4.67%
Neuberger Berman Disrupters ETF
4.34%
Fidelity Digital Health ETF
3.66%
Ver más
Langar Global HealthTech ETF
Proporción14.08%
iShares U.S. Medical Devices ETF
Proporción13.62%
Simplify Health Care ETF
Proporción6.65%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción6.58%
Global X Robotics & Artificial Intelligence ETF
Proporción6.53%
Invesco AI and Next Gen Software ETF
Proporción5%
Goldman Sachs Future Health Care Equity ETF
Proporción4.73%
iShares US Select Equity Active ETF
Proporción4.67%
Neuberger Berman Disrupters ETF
Proporción4.34%
Fidelity Digital Health ETF
Proporción3.66%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Aug 05, 2021
Split
1→3
Fecha
Tipo
Relación
Aug 05, 2021
Split
1→3
KeyAI